Sunday, November 15, 2020

More than 80% of Pfizer's vaccine doses have already been bought by world's richest

 "You couldn't get a clearer example of how unequal the pharmaceutical system is"

Medical syringes are seen with Pfizer company logo displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020. (Photo illustration by Jakub Porzycki/NurPhoto via Getty Images)

Julia Conley
Salon

Campaigners in the United Kingdom on Wednesday warned that just two days after pharmaceutical giant Pfizer shared positive early results of its coronavirus vaccine trial, mass purchases of the vaccine by the world's richest countries have left more than 85% of the global population—namely, the world's poorest—without any way to access it. 

Pfizer says it can produce 1.35 billion doses of the vaccine, which was shown according to Pfizer's first formal review to be 90% effective at preventing coronavirus infection in patients who have never had the virus, by the end of 2021. More than one billion of those doses—82% of the supply—have already been purchased by wealthy countries.  Read more >>